Once the acquisition is complete, Biomet Spine’s portfolio will include former Lanx systems such as the Timberline Lateral Approach Fusion System and the Aspen Minimally Invasive Fusion System.
The closing must be cleared under the Hart-Scott-Rodino Antitrust Improvements Act and is set to be finalized on or before Nov. 29.
More Articles on Devices:
19 Spine Devices Get FDA 510(k) Clearance in September
Spine Wave Implements iTraycer for Implants
X-Stop Spine Surgery: Outcomes Analysis
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
